By
Dr. Simon B Thompson
,
Mrs. Liliana Moyers Ruiz
Corresponding Author Dr. Simon B Thompson 
Psychology Research Centre , Bournemouth University, - United Kingdom BH12 5BB
Submitting Author Dr. Simon B Thompson 
Other Authors
Mrs. Liliana Moyers Ruiz 
Psychology Research Centre , Bournemouth University, - United Kingdom BH12 5BB
Cancer, Chemo-Brain, Chemo-Fog, Chemotherapy, Glucose Metabolism, Memory Loss, Oncology, Prospective Memory, Treatment, Working Memory
Thompson SB, Moyers Ruiz L. Chemo-brain - A New Entity?. WebmedCentral ONCOLOGY 2011;2(2):WMC001621
doi:
10.9754/journal.wmc.2011.001621
No
My opinion
Memory and language deficits in patients receiving chemotherapy have been noted; however, the aetiology is unknown. Particularly in the treatment of breast cancer, confounding factors include hormone therapy, and stress and anxiety during treatment. There are inconsistencies among clinical researchers over the neuropsychological correlates present in cancer survivors with some reports indicating that only a minority of patients have cognitive deficits that interfere with their every day life (Shilling & Jenkins, 2007).
Evidence from MRI scans of brain damage following radiotherapy and chemotherapy has been reported (Stewart, Bielajew, Collins, Parkinson, & Tomiak, 2006). Cognitive impairment, irrespective of education, profession, mood, or clinical characteristics, was found in terms of processing speed, attention, and learning (Wefel, Lenzi, Teriault, Davis & Meyers, 2004). Despite being subtle, these cognitive deficits led to functional loss manifested in decreased ability to work which is also associated with central toxicity.
Yet others have not found any difference in cognitive performance when comparing cardiac patients with cancer survivors and matched controls (Mehlsen, Pedersen, Jensen & Zachariae, 2009). The idea that patients may be conditioned to eliciting cognitive deficits as responses has also been proposed (Bovbjerg, Redd, Maier, Holland, Lesko & Niedzwiecki, 1990).
Receiving chemotherapy may function as a conditioned response giving rise to cognitive deficits and subsequent immunosuppression. Conditioned immuno-suppressionmay explain some of the undesirable and distressing effects of chemotherapy such as nausea, though this line of explanation is not entirely popular in light of the known toxicity of pharmaceuticals used in treatment of cancer patients.
The authors would welcome information and data to assist with their enquiry.
Reference(s)
1. Shilling V, Jenkins V, 2007. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing. Vol 11, No 1, 6-15.
2. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E, 2006. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychology. Vol 20, No 1, 79-89.
3. Wefel J, Lenzi R, Teriault R, Davis R, & Meyers C A, 2004. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of prospective, randomized, longitudinal trial. Cancer. Vol 100, 2292–9.
4. Mehlsen M, Pedersen A, Jensen A, Zachariae R, 2009. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology. Vol 18, 248–57.
5. Bovbjerg D, Redd W, Maier L, Holland J, Lesko L, Niedzwiecki D, 1990. Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer. Journal of Consulting & Clinical Psychology. Vol 58, No 2, 153-157.
Source(s) of Funding
Ethical approval - Not aplicable; Source of funding - None
Competing Interests
Competing interests - None
Disclaimer
This article has been downloaded from WebmedCentral. With our unique author driven post publication peer
review, contents posted on this web portal do not undergo any prepublication peer or editorial review. It is
completely the responsibility of the authors to ensure not only scientific and ethical standards of the manuscript
but also its grammatical accuracy. Authors must ensure that they obtain all the necessary permissions before
submitting any information that requires obtaining a consent or approval from a third party. Authors should also
ensure not to submit any information which they do not have the copyright of or of which they have transferred
the copyrights to a third party.
Contents on WebmedCentral are purely for biomedical researchers and scientists. They are not meant to cater to
the needs of an individual patient. The web portal or any content(s) therein is neither designed to support, nor
replace, the relationship that exists between a patient/site visitor and his/her physician. Your use of the
WebmedCentral site and its contents is entirely at your own risk. We do not take any responsibility for any harm
that you may suffer or inflict on a third person by following the contents of this website.